Strand AI
Multimodal foundation models to predict uncollected patient biology
Informazioni
Descrizione dell’azienda in inglese
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Temi
HealthcareDrug Discovery and Delivery
- Sede
- San Francisco, CA, USA
- Team
- 2 dipendenti
- Batch YC
- Winter 2026
- Stato
- Attiva
- Fase
- Fase iniziale
